The Interruption of Transmission of Onchocerciasis in Abia, Anambra, Enugu, and Imo States, Nigeria: The Largest Global Onchocerciasis Stop-Treatment Decision to Date
Pathogens · 2024
DOI: 10.3390/pathogens13080671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Cephas Ityonzughul und 18 weiteren Autor:innen. Beteiligte Einrichtung: The Carter Center, Jos 930104, Nigeria. Hauptthemen laut MEDLINE: Onchocerciasis, Onchocerca volvulus, Ivermectin, Simuliidae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: USAID, RTI International, Lions Clubs International Foundation.
Abstract (Originalsprache)
Onchocerciasis causes severe morbidity in sub-Saharan Africa. Abia, Anambra, Enugu, and Imo states of Nigeria were historically classified meso- or hyperendemic and eligible for ivermectin mass drug administration (MDA). After ≥25 years of annual and biannual MDA, serological and entomological assessments were conducted to determine if Onchocerca volvulus transmission was interrupted. Dried blood spots collected in October 2020 from ≥3167 children 5–9 years old in each state were screened for O. volvulus-specific Ov16 antibody by enzyme-linked immunosorbent assay. Additionally, 52,187 Simulium damnosum heads (≥8845 per state) collected over 12 months between 2021 and 2022 were tested by pooled polymerase chain reaction (PCR) for O-150 DNA. Among seven seropositive children, four were found for follow-up skin snip PCR to confirm active infection. Three were negative and the fourth was excluded as he was visiting from an endemic state. The final seroprevalence estimates of each state had 95% upper confidence limits (UCL) < 0.1%. All fly pools were negative by O-150 PCR, giving a 95% UCL infective fly prevalence < 0.05% in each state. Each state therefore met the World Health Organization epidemiological and entomological criteria for stopping MDA effective January 2023. With 18.9 million residents eligible for MDA, this marked the largest global onchocerciasis stop-treatment decision to date.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Carter Center, Jos 930104, Nigeria.
- The Carter Center, Atlanta, GA 30307, USA.
- Federal Ministry of Health and Social Welfare, Abuja 900242, Nigeria.
- Imo State Ministry of Health, Owerri 460281, Nigeria.
- Abia State Ministry of Health, Umuahia 440236, Nigeria.
- Anambra State Ministry of Health, Awka 420110, Nigeria.
ORCID-Profile: Jenna E Coalson, Emily Griswold, Gregory S Noland
Förderung
- USAID
- RTI International
- Lions Clubs International Foundation
- The Carter Center
- ENVISION
- RTI International, and the Lions Clubs International Foundation
Zitieren
APA
Ityonzughul, C., Sallau, A., Miri, E., Emukah, E., Kahansim, B., Adelamo, S., Chiedo, G., Ifeanyichukwu, S., Coalson, J. E., Rakers, L., Griswold, E., Makata, C., Oyediran, F., Osuji, S., Offor, S., Obikwelu, E., Otiji, I., Richards, F. O., & Noland, G. S. (2024). The Interruption of Transmission of Onchocerciasis in Abia, Anambra, Enugu, and Imo States, Nigeria: The Largest Global Onchocerciasis Stop-Treatment Decision to Date. Pathogens. https://doi.org/10.3390/pathogens13080671
Vancouver
Ityonzughul C, Sallau A, Miri E, Emukah E, Kahansim B, Adelamo S, et al. The Interruption of Transmission of Onchocerciasis in Abia, Anambra, Enugu, and Imo States, Nigeria: The Largest Global Onchocerciasis Stop-Treatment Decision to Date. Pathogens. 2024. doi:10.3390/pathogens13080671
BibTeX
@article{Ityonzughul2024,
author = {Ityonzughul, Cephas and Sallau, Adamu and Miri, Emmanuel and Emukah, Emmanuel and Kahansim, Barminas and Adelamo, Solomon and Chiedo, George and Ifeanyichukwu, Samuel and Coalson, Jenna E and Rakers, Lindsay and Griswold, Emily and Makata, Chukwuemeka and Oyediran, Fatai and Osuji, Stella and Offor, Solomon and Obikwelu, Emmanuel and Otiji, Ifeoma and Richards, Frank O and Noland, Gregory S},
title = {The Interruption of Transmission of Onchocerciasis in Abia, Anambra, Enugu, and Imo States, Nigeria: The Largest Global Onchocerciasis Stop-Treatment Decision to Date},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13080671}
}
EUVIMED